Clinical trial
SR-Registration Study 1, ROW: Efficacy and Safety of Seroquel® in the Treatment…
NCT00206115 · AstraZeneca, Industry · Completed
Key facts
| NCT number | NCT00206115 |
|---|---|
| Title | SR-Registration Study 1, ROW: Efficacy and Safety of Seroquel® in the Treatment of Patients With Schizophrenia |
| Official title | A 6-week, Multicenter, Double-blind, Double-dummy, Randomized Comparison of the Efficacy & Safety of Sustained-Release Formulation Quetiapine Fumarate (SEROQUEL) & Placebo in the Treatment of Acutely Ill Patients With Schizophrenia |
| Lead sponsor | AstraZeneca, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Schizophrenic Disorder |
| Intervention type | Drug |
| Interventions | Seroquel Sustained Release (SR), Seroquel Immediate Release (IR), Placebo |
| Enrollment | 535 |
| Start date | Nov 1, 2004 |
| Completion | Dec 1, 2005 |
| First posted | Sep 21, 2005 |
| Last update posted | Jan 4, 2013 |
| Countries | Bulgaria, Greece, India, Indonesia, Philippines, Romania, Russia, South Africa |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: